Pharmafile Logo

New Webinar: 2026 Engagement Strategies For Modern Pharma

Turn interaction into intelligence! Don’t miss this chance to lead the industry with our free pharma-exclusive webinar!

- PMLiVE

Why sink your entire budget into a one-off webinar that is forgotten the moment the “End Meeting” button is clicked? 2026 engagement will be defined by longitudinal strategy delivered in snackable doses. In a world that is always on, learn how to build an ecosystem where global stakeholders collaborate across 100+ languages and time zones, utilizing micro-modules and gamification to keep your brand at the center of the conversation and continuously gather insights all year long.

Join us on March 3 – 4 to master modern pharma strategies that eliminate content fatigue and turn longitudinal interaction into actionable clinical insights. Among other topics, we’ll cover how to:

  • Bridge the 2026 Engagement Gap: Move from “pushed” content to high-value “pull” experiences, evolving your strategy from passive webinars to immersive, longitudinal journeys.

  • Generate Interaction Insights: Move beyond vanity metrics to measure “Clinical Conviction.” Leverage AI summaries and instant data reporting to quantify changes in HCP treatment priorities.

  • Turn Digital Fatigue into Digital Magnetism: Discover how snackable microlearning3D HolovisionInteractive SlidesAI Avatars, and VR/AR for MOA visualization can spike knowledge retention by up to 70%.

  • Empower Key Initiatives: See how new virtual tools enhance everything from Advisory Boards and Global Investigator Meetings to Agile MSL Enablement and Product Launch Orchestration.

And so much more!

Click here to register!

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

The Future of Wearable and Implantable Devices

Nance Dicciani & Denise Devine, Co-founders of RTM Vital Signs, join Natalie Yeadon, Co-Founder & CEO at Impetus Digital. We explore continuous ambulatory vital sign monitoring using wearable and implantable devices....

Designing Ethical AI and Healthcare Technologies

Bryn Williams-Jones, Professor & Director of the Bioethics Program at ESPUM and Editor-in-Chief of the Canadian Journal of Bioethics discusses the bioethical challenges of innovative healthcare technologies such as AI, digital therapeutics,...

Attacking COVID-19 from All Angles

Michael Taylor, CEO & Founder of Environmental Surface Solutions, explores alternative and supplementary approaches to fighting COVID-19 and other pathogens. In particular, we focus on environmental solutions for not only eradicating...

Importance of Patient Advocacy in Improving Healthcare

Eva Villalba, Executive Director of the Quebec Cancer Coalition, explores the importance of patient advocacy in improving healthcare. Among many other things, we dive into how the industry can help support...

Improving Patient Care by Removing Barriers to Drug Accessibility

Alan Birch, Founder & President of Drug Access Canada, discusses all things drug access and reimbursement. Among many other things, we explore the hurdles faced by patients and drug access navigators and...

Reimagining the Patient Journey

Kimberly Tableman, CEO at Medicine X, discusses a myriad of topics related to digital transformation and patient centricity, including how digital health technologies can be used to reimagine the patient...

Environmental impact of in-person vs. virtual meetings

Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...

Leadership Lessons Learned from the Pandemic

Alok Kanti, President & CEO of Bayer Canada, discusses a variety of topics, including his experience with leading an entire organization through the COVID-19 pandemic and where he sees digital health...

Overcoming Behavioral Health Access Limitations Through Telemedicine

Phil Hirsh, PhD, Founder & Chief Executive at Synergia Integrated teleBehavioral Health; and Craig Wright, MD, Senior Physician Executive and Consultant, discuss a range of topics surrounding telemedicine and other digital health...

Commercial Execution Strategies During & After the Pandemic

Frank Armenante, Director of Commercial Execution at Novo Nordisk, discusses a range of topics, from the impact of COVID-19 on commercial operations and the digitization of Pharma to his leadership lessons...